First FDA-approved CAR-T Cell Therapy for Lymphoma to Be Available at City of Hope

October 18, 2017 | City of Hope

City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR-T therapy for adult patients for some types of non-Hodgkin lymphoma

Continue Reading

Prehistoric Virus May Hold Secret to Fighting Certain Types of Cancer

October 25, 2017 | Katie Neith

City of Hope researchers have found a link between a type of ancient RNA and a tumor suppressing gene.

First FDA-approved CAR-T Cell Therapy for Lymphoma to Be Available at City of Hope

October 18, 2017 | City of Hope

City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR-T therapy for adult patients for some types of non-Hodgkin lymphoma

Digital Technology and the Future of Cancer Care

October 12, 2017 | City of Hope

Smartphones and digital technology have become essential tools in our personal and professional lives. So it’s a natural next step that these technologies are being used to improve health care, too.

Genomics Will Reshape Cancer Care. Here's How.

September 28, 2017 | Abe Rosenberg

The exploding field of cancer genomics is enabling that kind of prediction for a growing number of inherited cancers, like identifying one of the many genes beyond BRCA1 and BRCA2 gene mutations linked to breast cancer.

Hyundai Young Investigator Grant goes to Leo Wang, M.D., Ph.D.

September 15, 2017 | Denise Heady

To help further City of Hope’s research in CAR-T therapy, Leo Wang, M.D., Ph.D., a dual-trained pediatric oncologist and scientist, was awarded with a Hyundai Young Investigator Grant funded by the Hyundai Hope On Wheels program.

'The Time Is Ripe': Bart Roep, Ph.D., on the Search for a T1D Cure

June 27, 2017 | Abe Rosenberg

Bart O. Roep, Ph.D., has dedicated his life to the search for a cure for type 1 diabetes. And he thinks he is on the brink. Roep, an internationally renowned immunologist who joined City of Hope last year from the Netherlands’ Leiden University Medical Center, was recently named the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes. He believes that this endowment and a $50 million funding project led by the Wanek family will be key in stopping the disease.

The Legacy of City of Hope’s Japanese-American scientists

June 6, 2017 | Letisia Marquez

City of Hope’s rich history is filled with stories of celebrated researchers who helped shape the course of modern medicine. Yoko Fujita-Yamaguchi, Ph.D., professor emeritus in the Diabetes & Metabolism Research Institute at City of Hope, has written a book in Japanese that delves into the contributions of Japanese-American scientists at City of Hope.

Live from ASCO: The Immunotherapy Revolution

June 4, 2017 | Cary A. Presant, M.D.

At ASCO 2017 in Chicago, we’ve been hearing about promising new clinical trials that have shown that immunotherapy can control some of the most resistant cancers.

Load More